Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Retained Earnings (2016 - 2025)

Mimedx (MDXG) has disclosed Retained Earnings for 15 consecutive years, with -$42.7 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 53.23% to -$42.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$42.7 million through Dec 2025, up 53.23% year-over-year, with the annual reading at -$42.7 million for FY2025, 53.23% up from the prior year.
  • Retained Earnings hit -$42.7 million in Q4 2025 for Mimedx, up from -$57.9 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$42.7 million in Q4 2025 to a low of -$196.9 million in Q1 2023.
  • Historically, Retained Earnings has averaged -$139.0 million across 5 years, with a median of -$160.7 million in 2021.
  • Biggest five-year swings in Retained Earnings: crashed 49.41% in 2021 and later skyrocketed 53.23% in 2025.
  • Year by year, Retained Earnings stood at -$161.7 million in 2021, then fell by 18.67% to -$191.9 million in 2022, then skyrocketed by 30.34% to -$133.7 million in 2023, then surged by 31.73% to -$91.3 million in 2024, then surged by 53.23% to -$42.7 million in 2025.
  • Business Quant data shows Retained Earnings for MDXG at -$42.7 million in Q4 2025, -$57.9 million in Q3 2025, and -$74.6 million in Q2 2025.